Effects of Comorbid Major Depressive Disorder and Heart Failure on Mortality
An article on the association between major depressive disorder on heart failure with reduced and preserved ejection fracture published in Cureus was recently picked up by PsychiatryAdvisor Read the Cureus article: Association of Major Depressive Disorder on Heart Failure With Reduced and Preserved Ejection Fraction: Analysis of National Readmission Database 2018 Click here to read the news story.
Jul 16, 2021
Call for Article Submissions: Alzheimer's & Brain Awareness
Call for Articles: Alzheimer's & Brain Awareness June is Alzheimer’s & Brain Awareness month. In honor of this important time to reflect, learn, and engage in neurological topics, we are asking our authors-- both new and veteran, to consider submitting research regarding Alzheimer’s and other neurodegenerative diseases such as dementia, Parkinson’s and Huntington’s. We also welcome other neurological or neuropsychological subjects inline with our brain awareness theme. For the opportunity to be featured on a devoted brain awareness results page, use keyword "Brain Awareness". Editors will consider original articles, case reports, review articles, and technical reports across a broad area of research in several specialties including: Neurology Neurosurgery Psychiatry Psychology Internal Medicine Family Practice Example topics include: Neuropsychological Cognitive screening tools and Assessments for Dementia Deep brain stimulation: engaging therapeutic circuits and networks in Alzheimer’s disease Attention, variability, and biomarkers in Alzheimer's Disease Depression and Alzheimer's disease Identification, diagnosis and treatment of prosopagnosia Mixed dementia: epidemiology, diagnosis, and treatment A systematic review of structural MRI investigations within borderline personality disorder
Jun 21, 2021
Drainage, Irrigation, and Fibrinolytic Therapy (DRIFT) for Adult Intraventricular Hemorrhage Using IRRAflow®
An article on drainage, irrigation, and fibrinolytic therapy (DRIFT) for adult intraventricular hemorrhage published in Cureus was picked up by Medical Device News Magazine Read the Cureus article here: Drainage, Irrigation, and Fibrinolytic Therapy (DRIFT) for Adult Intraventricular Hemorrhage Using IRRAflow® Self-Irrigating Catheter Article from Medical Device News Magazine *Thumbnail image from https://irras.com/
Jun 04, 2021
Using Platelet-Rich Plasma (PRP) Therapy to Efficiently Reduce Beard Hair Loss
Platelet-Rich Plasma (PRP) therapy is one of the most recent scientific advancements in the field of hair restoration. It’s simple, painless and relies on activating your body’s own healing capacities. Here is what you need to know about this procedure: What is Platelet-Rich Plasma (PRP) Therapy for beard hair loss? PRP therapy has already been successfully used for some time in treating other conditions, such as muscle, bone or joint injuries. However, it was only recently that its benefits in promoting hair growth and restoration have been scientifically verified. This quick and easy procedure involves drawing a little bit of your own blood, then using a special centrifuge to separate the substances in it. Once the nutrient-rich platelets, which are great at promoting tissue growth are isolated, they are injected into the balding areas on your chin. This leads to better vascularization, tissue healing and regeneration, which means your reinvigorated follicles will start producing a thick and healthy-looking beard. The procedure is no more painful than the sting of any injection, it is not invasive and carries no more risks than your average jab. Because it is your own blood that you are using, there is no chance of the body rejecting the platelets. Who can benefit from PRP therapy for beard hair loss? There is already mounting evidence that PRP can be very effective in treating androgenetic alopecia (male pattern baldness) in the beard area. However, new research indicates that it may also successfully treat alopecia areata of the beard – a relatively rare, auto-immune condition which leaves a pattern bald spots on your chin. PRP therapy can also help treat beard loss caused by trauma (if the scarring is not too severe), by resolved skin issues, or by aging. However, it is unlikely that this procedure will yield good results if your hair loss is caused by beard trichotillomania (pulling out your beard hair when stressed), chemotherapy, untreated dermatological conditions, extensive scarring etc. If you are unsure what is causing your beard hair to fall out or would like to be certain that PRP is the right choice for you, do not hesitate to schedule an appointment with a dermatologist. How much does PRP therapy for beard hair loss cost? A good price-quality ratio, offered by the well-reputed Wimpole Clinic in London, starts at $449 per PRP session. Given that 3-4 sessions, spaced out 4 weeks apart are normally required, followed by a booster session after 6-12 months, you should probably consider setting aside around $2,000-3,000 for the procedure in the first year.
May 21, 2021
Is There an Association Between Psoriasis/PsA and Thyroid Disease?
An article on the etiological association between psoriasis and thyroid diseases published in Cureus was recently picked up by RheumatologyAdvisor Read the Cureus article: The Etiological Association Between Psoriasis and Thyroid Diseases Click here to read the news story.
Apr 28, 2021
Strategies to Promote Long-Term Cardiac Implant Site Health Publishing Competition
The Strategies to Promote Long-Term Cardiac Implant Site Health publishing competition has come to a close and we are pleased to announce the winning articles based on highest Cureus SIQ score*! 1st place (8.54 SIQ) - $5,000 honorarium: 'Strategies to Promote Long-Term Cardiac Implant Site Health' by Taleski and Zafirovska 2nd place (8.39 SIQ) - $2,000 honorarium: 'Evidence-Based Strategies to Promote Long-Term Cardiac Implant Site Health: Review of the Literature' by Licari, Viola, Carolla, Campanella and Salamone 3rd place (8.16 SIQ) - $1,000 honorarium: 'Surgical Techniques, Complications, and Long-Term Health Effects of Cardiac Implantable Electronic Devices' by Richardson, Prempeh, Gordon, Poyser and Tiesenga Congratulations to the winning authors - we'll be contacting each submitting author to arrange for honorarium delivery, which includes the option of a cash distribution or equivalent donation made to the charity of their choice. We'd also like to thank the Cureus community and our sponsor, Aziyo Biologics, for making this competition a success. You can browse through the entire library of competition articles via the link below. https://www.cureus.com/competitions/cardimplanthealth
Mar 05, 2021
Research into Covid-19 Induced Blindness
An article published in Cureus regarding cortical blindness following Posterior Reversible Encephalopathy Syndrome (PRES) as a complication of COVID-19 Pneumonia was recently picked up by Punch Healthwise, Prompt News Online, Urdu Point News, Sputnik News, and World Stage. Read the Cureus article here: Persistent Cortical Blindness Following Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of COVID-19 Pneumonia
Feb 19, 2021
The Flu Vaccination, COVID-19, and the Pediatric Population
An article on the effect of the flu vaccination on the pediatric population published in Cureus was picked up by WebMD.com Read the Cureus article here: The Flu Vaccination May Have a Protective Effect on the Course of COVID-19 in the Pediatric Population: When Does Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Meet Influenza?
Feb 11, 2021